ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,778,174, issued on Nov. 3, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland).
"Compositions for use in the reduction of nociception and other health benefits in infants and young children" was invented by Sami Damak (Lausanne, Switzerland), Norbert Sprenger (Savigny, Switzerland), Francis Foata (Belmont-sur-Lausanne, Switzerland), Florence Rochat (Montreux, Switzerland) and Claire Laurence Lucie Marie Boulange (Lausanne, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compositions comprising 2'-Fucosyllactose (2'-FL), for use in the reduction of nociception in an infant or in a young child b...